GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (BOM:500674) » Definitions » Common Stock

Sanofi India (BOM:500674) Common Stock : ₹0 Mil (As of Sep. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Sanofi India Common Stock?

Sanofi India's quarterly common stock increased from Mar. 2024 (₹0 Mil) to Jun. 2024 (₹230 Mil) but then declined from Jun. 2024 (₹230 Mil) to Sep. 2024 (₹0 Mil).

Sanofi India's annual common stock stayed the same from Dec. 2021 (₹230 Mil) to Dec. 2022 (₹230 Mil) and stayed the same from Dec. 2022 (₹230 Mil) to Dec. 2023 (₹230 Mil).


Sanofi India Common Stock Historical Data

The historical data trend for Sanofi India's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi India Common Stock Chart

Sanofi India Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 230.00 230.00 230.00 230.00 230.00

Sanofi India Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 230.00 - 230.00 -

Sanofi India Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Sanofi India Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth.

Sanofi India Headlines

No Headlines